CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
NCT Number: NCT01196754
This is a prospective clinical monocentric study in ICU with sedated ventilated patients with sevoflurane during 48 h with the AnaConda® system, establishing pharmacokinetic model of sevoflurane.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Clermont-Ferrand, 63003, France
Prospective clinical monocentric study in ICU with sedated ventilated patients with sevoflurane during 48 h with the AnaConda® system, establishing pharmacokinetic model of sévoflurane and its metabolites (hydroxyfluroisopropanol, fluoride)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: during 48 hours
Time frame: during 48 hours
University Hospital, Clermont-Ferrand
Other
Pharmacokinetic of Sevoflurane During a 48h Sedation in ICU With AnaConDa®
Acronym: Anaconda
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07676955
Cesarean Birth, Sedation
Istanbul, Sultangazi, Turkey (Türkiye)
View Trial DetailsNCT06538883
Mechanical Ventilation, Sedation
Nanjing, Jiangsu, China
View Trial DetailsNCT07580768
Dexmedetomidine, Double-J Ureteral Stent
Tanta, El-Gharbia, Egypt
View Trial DetailsNCT05559970
ICU, Lung Diseases
Bangkok Noi, Bangkok, Thailand
View Trial Details